Annual Total Expenses
$12.73 M
+$217.90 K+1.74%
June 30, 2024
Summary
- As of February 7, 2025, INM annual total expenses is $12.73 million, with the most recent change of +$217.90 thousand (+1.74%) on June 30, 2024.
- During the last 3 years, INM annual total expenses has risen by +$2.79 million (+28.11%).
- INM annual total expenses is now -14.44% below its all-time high of $14.88 million, reached on June 30, 2022.
Performance
INM Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.02 M
-$273.20 K-8.30%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly total expenses is $3.02 million, with the most recent change of -$273.20 thousand (-8.30%) on September 30, 2024.
- Over the past year, INM quarterly total expenses has increased by +$50.10 thousand (+1.69%).
- INM quarterly total expenses is now -34.04% below its all-time high of $4.58 million, reached on December 31, 2021.
Performance
INM Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
INM Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.7% | +1.7% |
3 y3 years | +28.1% | -15.3% |
5 y5 years | +22.5% | +56.1% |
INM Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -14.4% | +28.1% | -34.0% | +11.7% |
5 y | 5-year | -14.4% | +39.1% | -34.0% | +93.5% |
alltime | all time | -14.4% | >+9999.0% | -34.0% | +133.9% |
InMed Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.02 M(-8.3%) |
Jun 2024 | $12.73 M(+1.7%) | $3.29 M(+10.9%) |
Mar 2024 | - | $2.97 M(+0.8%) |
Dec 2023 | - | $2.94 M(-16.5%) |
Sep 2023 | - | $3.53 M(+24.7%) |
Jun 2023 | $12.51 M(-15.9%) | $2.83 M(-11.2%) |
Mar 2023 | - | $3.18 M(+17.7%) |
Dec 2022 | - | $2.70 M(-28.8%) |
Sep 2022 | - | $3.80 M(+6.7%) |
Jun 2022 | $14.88 M(+49.7%) | $3.56 M(-7.5%) |
Mar 2022 | - | $3.85 M(-15.9%) |
Dec 2021 | - | $4.58 M(+58.2%) |
Sep 2021 | - | $2.89 M(-12.5%) |
Jun 2021 | $9.94 M(+8.6%) | $3.31 M(+5.5%) |
Mar 2021 | - | $3.13 M(+62.0%) |
Dec 2020 | - | $1.93 M(+23.7%) |
Sep 2020 | - | $1.56 M(+0.2%) |
Jun 2020 | $9.15 M(-12.0%) | $1.56 M(-29.2%) |
Mar 2020 | - | $2.20 M(-12.1%) |
Dec 2019 | - | $2.51 M(-12.9%) |
Sep 2019 | - | $2.88 M(-15.2%) |
Jun 2019 | $10.39 M(+58.8%) | $3.39 M(+28.5%) |
Mar 2019 | - | $2.64 M(+23.1%) |
Dec 2018 | - | $2.15 M(-4.2%) |
Sep 2018 | - | $2.24 M(-1.3%) |
Jun 2018 | $6.55 M(+90.3%) | $2.27 M(+35.9%) |
Mar 2018 | - | $1.67 M(+35.9%) |
Dec 2017 | - | $1.23 M(-16.0%) |
Sep 2017 | - | $1.46 M(-1.8%) |
Jun 2017 | $3.44 M(+87.2%) | $1.49 M(+60.3%) |
Mar 2017 | - | $929.40 K(+32.9%) |
Dec 2016 | - | $699.40 K(+118.7%) |
Sep 2016 | - | $319.80 K(-19.3%) |
Jun 2016 | $1.84 M(-46.8%) | $396.10 K(+35.0%) |
Mar 2016 | - | $293.40 K(-47.4%) |
Dec 2015 | - | $558.30 K(+8.1%) |
Sep 2015 | - | $516.50 K(-57.5%) |
Jun 2015 | $3.46 M(+200.2%) | $1.21 M(-5.0%) |
Mar 2015 | - | $1.28 M(+161.1%) |
Dec 2014 | - | $489.70 K(-16.2%) |
Sep 2014 | - | $584.50 K(-42.4%) |
Jun 2014 | $1.15 M(+2365.3%) | $1.01 M(+999.5%) |
Mar 2014 | - | $92.30 K(+162.2%) |
Dec 2013 | - | $35.20 K(+220.0%) |
Sep 2013 | - | $11.00 K(-51.8%) |
Jun 2013 | $46.70 K | $22.80 K(+200.0%) |
Mar 2013 | - | $7600.00(-226.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | -$6000.00(-126.2%) |
Sep 2012 | - | $22.90 K(-70.1%) |
Jun 2012 | $168.60 K(-62.5%) | $76.60 K(+237.4%) |
Mar 2012 | - | $22.70 K(-13.7%) |
Dec 2011 | - | $26.30 K(-35.5%) |
Sep 2011 | - | $40.80 K(-60.4%) |
Jun 2011 | $449.90 K(-8.4%) | $103.00 K(-57.1%) |
Mar 2011 | - | $240.30 K(+442.4%) |
Dec 2010 | - | $44.30 K(-22.8%) |
Sep 2010 | - | $57.40 K(-71.7%) |
Jun 2010 | $490.90 K(-48.1%) | $202.60 K(+115.3%) |
Mar 2010 | - | $94.10 K(+4.0%) |
Dec 2009 | - | $90.50 K(-6.2%) |
Sep 2009 | - | $96.50 K(-25.4%) |
Jun 2009 | $945.40 K(-50.1%) | $129.30 K(+27.3%) |
Mar 2009 | - | $101.60 K(-64.9%) |
Dec 2008 | - | $289.40 K(-43.6%) |
Sep 2008 | - | $512.90 K(-33.3%) |
Jun 2008 | $1.89 M(-3.8%) | $769.10 K(+92.7%) |
Mar 2008 | - | $399.10 K(-52.6%) |
Dec 2007 | - | $841.30 K(+62.5%) |
Sep 2007 | - | $517.80 K(-105.8%) |
Jun 2007 | $1.97 M(-50.0%) | -$8.91 M(-1450.7%) |
Mar 2007 | - | $659.50 K(-27.9%) |
Dec 2006 | - | $914.90 K(+29.1%) |
Sep 2006 | - | $708.80 K(-20.6%) |
Jun 2006 | $3.93 M(-36.8%) | $892.50 K(-12.4%) |
Mar 2006 | - | $1.02 M(-11.8%) |
Dec 2005 | - | $1.15 M(+7.3%) |
Sep 2005 | - | $1.08 M(-39.5%) |
Jun 2005 | $6.22 M(+86.6%) | $1.78 M(+9.5%) |
Mar 2005 | - | $1.63 M(+1.0%) |
Dec 2004 | - | $1.61 M(+35.7%) |
Sep 2004 | - | $1.19 M(+31.2%) |
Jul 2004 | $3.34 M(+127.4%) | $903.50 K(+15.3%) |
Apr 2004 | - | $783.70 K(-1.1%) |
Jan 2004 | - | $792.70 K(-13.6%) |
Oct 2003 | - | $917.50 K(+57.3%) |
Jul 2003 | $1.47 M(-47.0%) | $583.20 K(+143.1%) |
Apr 2003 | - | $239.90 K(-12.8%) |
Jan 2003 | - | $275.10 K(-14.8%) |
Oct 2002 | - | $322.90 K(-44.1%) |
Jul 2002 | $2.77 M(-35.0%) | $577.30 K(-15.6%) |
Apr 2002 | - | $684.30 K(-6.2%) |
Jan 2002 | - | $729.70 K(-3.7%) |
Oct 2001 | - | $757.70 K |
Jul 2001 | $4.26 M | - |
FAQ
- What is InMed Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual total expenses year-on-year change?
- What is InMed Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly total expenses year-on-year change?
What is InMed Pharmaceuticals annual total expenses?
The current annual total expenses of INM is $12.73 M
What is the all time high annual total expenses for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual total expenses is $14.88 M
What is InMed Pharmaceuticals annual total expenses year-on-year change?
Over the past year, INM annual total expenses has changed by +$217.90 K (+1.74%)
What is InMed Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of INM is $3.02 M
What is the all time high quarterly total expenses for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly total expenses is $4.58 M
What is InMed Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, INM quarterly total expenses has changed by +$50.10 K (+1.69%)